Literature DB >> 31368654

Management of the "notorious" refractory orthostatic hypotension: Let's think and further study droxidopa.

Kyriakos Dimitriadis1, Costas Tsioufis1, Dimitris Tousoulis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31368654      PMCID： PMC8030290          DOI： 10.1111/jch.13618

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  8 in total

1.  2018 ESC/ESH Guidelines for the management of arterial hypertension.

Authors:  Bryan Williams; Giuseppe Mancia; Wilko Spiering; Enrico Agabiti Rosei; Michel Azizi; Michel Burnier; Denis L Clement; Antonio Coca; Giovanni de Simone; Anna Dominiczak; Thomas Kahan; Felix Mahfoud; Josep Redon; Luis Ruilope; Alberto Zanchetti; Mary Kerins; Sverre E Kjeldsen; Reinhold Kreutz; Stephane Laurent; Gregory Y H Lip; Richard McManus; Krzysztof Narkiewicz; Frank Ruschitzka; Roland E Schmieder; Evgeny Shlyakhto; Costas Tsioufis; Victor Aboyans; Ileana Desormais
Journal:  Eur Heart J       Date:  2018-09-01       Impact factor: 29.983

2.  Management of supine hypertension in patients with neurogenic orthostatic hypotension: scientific statement of the American Autonomic Society, European Federation of Autonomic Societies, and the European Society of Hypertension.

Authors:  Jens Jordan; Alessandra Fanciulli; Jens Tank; Giovanna Calandra-Buonaura; William P Cheshire; Pietro Cortelli; Sabine Eschlboeck; Guido Grassi; Max J Hilz; Horacio Kaufmann; Heinz Lahrmann; Giuseppe Mancia; Gert Mayer; Lucy Norcliffe-Kaufmann; Anne Pavy-Le Traon; Satish R Raj; David Robertson; Isabel Rocha; Hannes Reuter; Walter Struhal; Roland D Thijs; Konstantinos P Tsioufis; J Gert van Dijk; Gregor K Wenning; Italo Biaggioni
Journal:  J Hypertens       Date:  2019-08       Impact factor: 4.844

3.  2018 ESC Guidelines for the diagnosis and management of syncope.

Authors:  Michele Brignole; Angel Moya; Frederik J de Lange; Jean-Claude Deharo; Perry M Elliott; Alessandra Fanciulli; Artur Fedorowski; Raffaello Furlan; Rose Anne Kenny; Alfonso Martín; Vincent Probst; Matthew J Reed; Ciara P Rice; Richard Sutton; Andrea Ungar; J Gert van Dijk
Journal:  Eur Heart J       Date:  2018-06-01       Impact factor: 29.983

Review 4.  Droxidopa: a review of its use in symptomatic neurogenic orthostatic hypotension.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2015-02       Impact factor: 9.546

5.  Orthostatic hypotension: definition, classification and evaluation.

Authors:  Irma Tzur; Shimon Izhakian; Oleg Gorelik
Journal:  Blood Press       Date:  2019-04-15       Impact factor: 2.835

6.  Orthostatic blood pressure measurements are often overlooked during the initial evaluation of syncope in the emergency department.

Authors:  Micah L A Heldeweg; Pedro J F Jorge; Jack J M Ligtenberg; Jan C Ter Maaten; Mark P M Harms
Journal:  Blood Press Monit       Date:  2018-12       Impact factor: 1.444

7.  Initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients.

Authors:  Katherine E McDonell; Brock A Preheim; Andre' Diedrich; James A S Muldowney; Amanda C Peltier; David Robertson; Italo Biaggioni; Cyndya A Shibao
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-08-01       Impact factor: 2.885

8.  Use of droxidopa for the long-term treatment of neurogenic orthostatic hypotension.

Authors:  Satish R Raj; Lawrence Arthur Hewitt
Journal:  Eur Heart J       Date:  2019-01-01       Impact factor: 29.983
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.